Immunoglobulins in children with epilepsy: The Dutch study of epilepsy in childhood

Clinical and Experimental Immunology

Volumn 132, Issue 1, 2003, Pages 144-151

  Callenbach, P M C ^a   Jol Van Der Zijde, C M ^a   Geerts, A T ^b   Arts, W F M ^c   Van Donselaar, C A ^d   Peters, A C B ^d   Stroink, H ^e   Brouwer, O F ^a,f   Van Tol, M J D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e CPRLab   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Carbamazepine; Children; Epilepsy; Immunoglobulins; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4; VALPROIC ACID;

ADOLESCENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; EPILEPSY; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NETHERLANDS; PRIORITY JOURNAL;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; INFANT; MALE; NETHERLANDS; STATISTICS, NONPARAMETRIC; VALPROIC ACID;

EID: 0242500309     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02097.x     Document Type: Article

References (27)

1. Palace J, Lang B. Epilepsy: an autoimmune disease? J Neurol Neurosurg Psychiatry 2000; 69:711-4.
2. Aarli JA. Epilepsy and the immune system. Arch Neurol 2000; 57:1689-92.
3. Rogers SW, Andrews PI, Gahring LC et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994; 265:648-51.
4. van Engelen BG, Renier WO, Weemaes CM, Gabreels FJ, Meinardi H. Immunoglobulin treatment in epilepsy, a review of the literature. Epilepsy Res 1994; 19:181-90.
5. Duse M, Notarangelo LD, Tiberti S, Menegati E, Plebani A, Ugazio AG. Intravenous immune globulin in the treatment of intractable childhood epilepsy. Clin Exp Immunol 1996; 104 (Suppl. 1):71-6.
6. Seager J, Jamison DL, Wilson J, Hayward AR, Soothill JF. IgA deficiency, epilepsy, and phenytoin treatment. Lancet 1975; 2:632-5.
7. Aarli JA. Changes in serum immunoglobulin levels during phenytoin treatment of epilepsy. Acta Neurol Scand 1976; 54:423-30.
8. Gilhus NE, Aarli JA. The reversibility of phenytoin-induced IgA deficiency. J Neurol 1981; 226:53-61.
9. Gilhus NE, Lea T. IgG subclasses in epileptic patients treated with phenytoin. J Neurol 1989; 236:149-52.
10. Gilhus NE, Strandjord RE, Aarli JA. The effect of carbamazepine on serum immunoglobulin concentrations. Acta Neurol Scand 1982; 66:172-9.
11. Gilhus NE, Lea T. Carbamazepine: effect on IgG subclasses in epileptic patients. Epilepsia 1988; 29:317-20.
12. Pacifici R, Paris L, Di Carlo S, Pichini S, Zuccaro P. Immunologic aspects of carbamazepine treatment in epileptic patients. Epilepsia 1991; 32:122-7.
13. Basaran N, Hincal F, Kansu E, Ciger A. Humoral and cellular immune parameters in untreated and phenytoin- or carbamazepine-treated epileptic patients. Int J Immunopharmacol 1994; 16:1071-7.
14. Garzon P, Gonzalez-Cornejo S, Roman-Maldonado S, Navarro-Ruiz A. Valproic acid and phenytoin effects on serum proteins and immunoglobulins of epileptic patients. General Pharmacol 1985; 16:411-3.
15. Bostantjopoulou S, Hatzizisi O, Argyropoulou O et al. Immunological parameters in patients with epilepsy. Funct Neurol 1994; 9:11-5.
16. Hemingway C, Leary M, Riordan G, Schlegal B, Walker K. The effect of carbamazepine and sodium valproate on the blood and serum values of children from a third-world environment. J Child Neurol 1999; 14:751-3.
17. Peters ACB, Brouwer OF, Geerts AT, Arts WFM, Stroink H, van Donselaar CA. Randomized prospective study of early discontinuation of antiepileptic drugs in children with epilepsy. Neurology 1998; 50:724-30.
18. Stroink H, Brouwer OF, Arts WFM, Geerts AT, Peters ACB, van Donselaar CA. The first unprovoked, untreated seizure in childhood: a hospital based study of the accuracy of the diagnosis, rate of recurrence, and long term outcome after recurrence. The Dutch Study of Epilepsy in Childhood. J Neurol Neurosurg Psychiatry 1998; 64:595-600.
19. Arts WFM, Geerts AT, Brouwer OF, Peters ACB, Stroink H, van Donselaar CA. The early prognosis of epilepsy in childhood: the prediction of a poor outcome. The Dutch Study of Epilepsy in Childhood. Epilepsia 1999; 40:726-34.
20. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981; 22:489-501.
21. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30:389-99.
22. Commission on Epidemiology and Prognosis ILAE. Guidelines for epidemiologic studies on epilepsy. Epilepsia 1993; 34:592-6.
23. Jol-Van der Zijde CM, Labadie J, Vlug A, Radl J, Vossen JM, Van Tol MJ. Dot-immunobinding assay as an accurate and versatile technique for the quantification of human IgG subclasses. J Immunol Meth 1988; 108:195-203.
24. Cejka J, Mood DW, Kim CS. Immunoglobulin concentrations in sera of normal children: quantitation against an international reference preparation. Clin Chem 1974; 20:656-9.
25. Central Laboratory of the Netherlands Red Cross Blood Transfusion Service (CLB). Vademecum Diagnostic Research: Amsterdam, The Netherlands 1997.
26. Lenti C, Masserini C, Peruzzi C, Guareschi CA. Effects of carbamazepine and valproate on immunological assessment in young epileptic patients. Ital J Neurol Sci 1991; 12:87-91.
27. De Sarro GB, Berlinghieri MC, Elia M et al. Does antiepileptic therapy affect immune response? J Chemother 1998; 10:184-6.